MCrew
REGISTER
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

MCrew

View Profile

Base

Bio

I am a Stage IV metastatic melanoma survivor, cancer free since September 2021,  thanks to Relativity-047 clinical trial. I received the combination of Relatlimab, a LAG-3–blocking antibody, and Nivolumab, a PD-1–blocking antibody during the clinical trial.  I stopped immunotherapy infusions beginning January 2023 because the immunotherapy related adverse effect of Fatigue was becoming debilitating.
Display Name

MCrew
I am

the patient
Initial Diagnosis Month

March
Initial Diagnosis Year

2021
Stage at Diagnosis

Stage 4
About the MRF Patient Forum

The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.